NEWS

Coronavirus cases in Nigeria rises to 276 as NCDC announces 22 new cases

The Nigerian Centre for Disease Control (NCDC) on Wednesday, April 8; announced the discovery of 22 new coronavirus cases in the country.

This was contained in a statement issued via its Twitter handle.

“Twenty-two new cases of coronavirus have been reported in Nigeria: 15 in Lagos, 4 in the FCT, 2 in Bauchi, 1 in Edo.

“As at 09:00 pm 8th April there are 276 confirmed cases of coronavirus reported in Nigeria. Forty-four have been discharged with six deaths.”

 

Meanwhile, the National Agency for Food and Drug Administration and Control (NAFDAC) on Monday, April 7; alerted Nigerians on the circulation of falsified chloroquine phosphate 250mg tablets.

In a statement, equally important, the Director-General of the agency; Prof Mojisola Adeyeye, said the NAFDAC was notified by the World Health Organisation (WHO) of the circulation of the tablets in Cameroon.

“The falsified chloroquine phosphate 250mg tablets were manufactured by Jiangsu pharmaceutical Inc, Astral pharmaceutical New Bhupalpura, China.

“The tablets manufactured by these companies have no Active Pharmaceutical Ingredient (API); and are in packs of 1000 tablets.

“The use of the falsified chloroquine phosphate 250mg tablets may result in treatment failure; and could even cause death,” she warned.

She also explained the labelling information on the falsified chloroquine phosphate 250mg tablets manufactured by Jiangsu pharmaceutical Inc, China is labelled with fake NAFDAC No.: 028060.

“The Astral pharmaceuticals, New Bhupalpura, China is labelled with fake NAFDAC registration No. 0587612 and advised the general public to be aware of this drug.

“All importers, wholesalers and retailers are hereby cautioned to desist from illegal importation; distribution as well as sale of falsified chloroquine phosphate 250mg tablets.

“NAFDAC has strengthened its surveillance in all ports of entry to prevent illegal importation of the falsified chloroquine phosphate 250mg tablets.

“The agency has also heightened surveillance in the 36 states and the Federal Capital Territory (FCT) to prevent distribution and sale of this falsified drug.

“Healthcare providers and other members of the public are advised to be vigilant and contact the nearest NAFDAC office with any information on the falsified chloroquine,” she said.

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close
Close